China · Delayed Price · Currency is CNY Sinocare Statistics
Total Valuation
Sinocare has a market cap or net worth of CNY 8.48 billion. The enterprise value is 8.75 billion.
| Market Cap | 8.48B |
| Enterprise Value | 8.75B |
Important Dates
The last earnings date was Tuesday, August 4, 2026.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
Sinocare has 533.24 million shares outstanding. The number of shares has decreased by -1.73% in one year.
| Current Share Class | 533.24M |
| Shares Outstanding | 533.24M |
| Shares Change (YoY) | -1.73% |
| Shares Change (QoQ) | -0.86% |
| Owned by Insiders (%) | 52.36% |
| Owned by Institutions (%) | 12.94% |
| Float | 248.53M |
Valuation Ratios
The trailing PE ratio is 64.85 and the forward PE ratio is 21.45. Sinocare's PEG ratio is 0.20.
| PE Ratio | 64.85 |
| Forward PE | 21.45 |
| PS Ratio | 1.72 |
| PB Ratio | 2.50 |
| P/TBV Ratio | 4.47 |
| P/FCF Ratio | 19.96 |
| P/OCF Ratio | 14.90 |
| PEG Ratio | 0.20 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.12, with an EV/FCF ratio of 20.59.
| EV / Earnings | 65.65 |
| EV / Sales | 1.77 |
| EV / EBITDA | 19.12 |
| EV / EBIT | 29.29 |
| EV / FCF | 20.59 |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.23 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 2.12 |
| Debt / FCF | 2.29 |
| Interest Coverage | 7.67 |
Financial Efficiency
Return on equity (ROE) is 1.86% and return on invested capital (ROIC) is 4.39%.
| Return on Equity (ROE) | 1.86% |
| Return on Assets (ROA) | 3.12% |
| Return on Invested Capital (ROIC) | 4.39% |
| Return on Capital Employed (ROCE) | 7.65% |
| Weighted Average Cost of Capital (WACC) | 3.43% |
| Revenue Per Employee | 987,726 |
| Profits Per Employee | 26,698 |
| Employee Count | 4,994 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 3.49 |
Taxes
In the past 12 months, Sinocare has paid 68.70 million in taxes.
| Income Tax | 68.70M |
| Effective Tax Rate | 50.74% |
Stock Price Statistics
The stock price has decreased by -24.63% in the last 52 weeks. The beta is -0.12, so Sinocare's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | -24.63% |
| 50-Day Moving Average | 15.37 |
| 200-Day Moving Average | 16.70 |
| Relative Strength Index (RSI) | 49.11 |
| Average Volume (20 Days) | 7,025,426 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sinocare had revenue of CNY 4.93 billion and earned 133.33 million in profits. Earnings per share was 0.25.
| Revenue | 4.93B |
| Gross Profit | 2.40B |
| Operating Income | 298.79M |
| Pretax Income | 135.38M |
| Net Income | 133.33M |
| EBITDA | 444.31M |
| EBIT | 298.79M |
| Earnings Per Share (EPS) | 0.25 |
Balance Sheet
The company has 1.02 billion in cash and 972.57 million in debt, with a net cash position of 43.68 million or 0.08 per share.
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 972.57M |
| Net Cash | 43.68M |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 3.39B |
| Book Value Per Share | 5.78 |
| Working Capital | 472.61M |
Cash Flow
In the last 12 months, operating cash flow was 569.27 million and capital expenditures -144.15 million, giving a free cash flow of 425.12 million.
| Operating Cash Flow | 569.27M |
| Capital Expenditures | -144.15M |
| Depreciation & Amortization | 145.52M |
| Net Borrowing | 160.45M |
| Free Cash Flow | 425.12M |
| FCF Per Share | 0.80 |
Margins
Gross margin is 48.74%, with operating and profit margins of 6.06% and 2.70%.
| Gross Margin | 48.74% |
| Operating Margin | 6.06% |
| Pretax Margin | 2.74% |
| Profit Margin | 2.70% |
| EBITDA Margin | 9.01% |
| EBIT Margin | 6.06% |
| FCF Margin | 8.62% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.38%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 1.38% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 12.56% |
| Buyback Yield | 1.73% |
| Shareholder Yield | 3.11% |
| Earnings Yield | 1.57% |
| FCF Yield | 5.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Sinocare is 22.88, which is 43.81% higher than the current price. The consensus rating is "Buy".
| Price Target | 22.88 |
| Price Target Difference | 43.81% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 9.57% |
| EPS Growth Forecast (3Y) | 103.87% |
Stock Splits
The last stock split was on July 16, 2018. It was a forward split with a ratio of 1.2.
| Last Split Date | Jul 16, 2018 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Sinocare has an Altman Z-Score of 3.88 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.88 |
| Piotroski F-Score | 6 |